The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs
Open accessAbstract
The last 50 years of hepatitis B research has resulted in the development of effective screening assays for surveillance, vaccines for prevention and antiviral drugs that significantly improve patient clinical outcomes. Not surprisingly then, the global epidemiology of hepatitis B virus (HBV) is set to change dramatically over the next decade. For example, the success and the high coverage of universal HBV vaccination and the ageing cohorts of patients with chronic hepatitis B (CHB) will result in reductions of incidence and prevalence of chronic hepatitis, cirrhosis and probably hepatocellular carcinoma. This will be further accelerated by the impressive progress in the treatment outcomes for patients with CHB. In spite of this success, challenges remain, such as planning for the impact of migration from countries with high prevalence rates to those countries with low rates of HBV infection. The recent establishment of the World Health Organisation Global Hepatitis Program with the provision of a framework for global action has become the cornerstone for all countries to now frame their own particular national responses to control hepatitis B. An effective policy framework can prevent new infections, ensure people can access clinical care, and in doing so reduce the burden of infection at an individual, country and regional level. These developments present a real opportunity to reduce the significant, social and economic burden of global hepatitis B, ultimately the critical next steps to render the world hepatitis B free.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.010 · Cited by 2,925
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Self-citationLamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
Self-citationOtt, J. J., Stevens, G. A., Groeger, J., & Wiersma, S. T. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.116 · Cited by 1,843
Marcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
Fattovich, G., Bortolotti, F., & Donato, F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.011 · Cited by 1,348
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Lu, S.-N., Liaw, Y.-F., You, S.-L., Sun, C.-A., Wang, L.-Y., Hsiao, C. K., Chen, P.-J., Chen, D.-S., & Chen, C.-J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,222
Self-citationSzmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Oleszko, W. R., William, D. C., Sadovsky, R., Morrison, J. M., & Kellner, A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010093031501 · Cited by 1,100
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Liaw, Y.-F., Kao, J.-H., Piratvisuth, T., Chan, H. L. Y., Chien, R.-N., Liu, C.-J., Gane, E., Locarnini, S., Lim, S.-G., Han, K.-H., et al. (2012) · Hepatology International · doi:10.1007/s12072-012-9365-4 · Cited by 1,038
Self-citationSynthesis and assembly of hepatitis B virus surface antigen particles in yeast
Valenzuela, P., Medina, A., Rutter, W. J., Ammerer, G., & Hall, B. D. (1982) · Nature · doi:10.1038/298347a0 · Cited by 877
Global control of hepatitis B virus infection
Kao, J.-H., & Chen, D.-S. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00315-8 · Cited by 805
Self-citationHepatitis B Virus Resistance to Nucleos(t)ide Analogues
Zoulim, F., & Locarnini, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.063 · Cited by 706
Self-citationDecreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Chang, M.-H., You, S.-L., Chen, C.-J., Liu, C.-J., Lee, C.-M., Lin, S.-M., Chu, H.-C., Wu, T.-C., Yang, S.-S., Kuo, H.-S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp288 · Cited by 635
Self-citationAlter, M. J. (1990) · JAMA · doi:10.1001/jama.263.9.1218 · Cited by 458
Kramvis, A., Kew, M., & François, G. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.10.045 · Cited by 394
Xu, W. ‐., Cui, Y. ‐., Wang, L., Yang, H., Liang, Z. ‐., Li, X. ‐., Zhang, S. ‐., Qiao, F. ‐., Campbell, F., Chang, C. ‐., et al. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2008.01056.x · Cited by 387
Boni, C., Laccabue, D., Lampertico, P., Giuberti, T., Viganò, M., Schivazappa, S., Alfieri, A., Pesci, M., Gaeta, G. B., Brancaccio, G., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.014 · Cited by 377
Han, G.-R., Cao, M.-K., Zhao, W., Jiang, H.-X., Wang, C.-M., Bai, S.-F., Yue, X., Wang, G.-J., Tang, X., & Fang, Z.-X. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.032 · Cited by 363
Posttransfusion Hepatitis After Exclusion of Commercial and Hepatitis-B Antigen-Positive Donors
ALTER, H. J., HOLLAND, P. V., PURCELL, R. H., LANDER, J. J., FEINSTONE, S. M., MORROW, A. G., & SCHMIDT, P. J. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-5-691 · Cited by 354
Hadziyannis, S. J., Sevastianos, V., Rapti, I., Vassilopoulos, D., & Hadziyannis, E. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.039 · Cited by 347
Chen, D.-S. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390190075023 · Cited by 333
Self-citationChen, J., Yang, H., Iloeje, U. H., You, S., Lu, S., Wang, L., Su, J., Sun, C., Liaw, Y., & Chen, C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.042 · Cited by 331
Hepatitis B virus genetic variability and evolution
Kay, A., & Zoulim, F. (2007) · Virus Research · doi:10.1016/j.virusres.2007.02.021 · Cited by 278
Wen, W.-H., Chang, M.-H., Zhao, L.-L., Ni, Y.-H., Hsu, H.-Y., Wu, J.-F., Chen, P.-J., Chen, D.-S., & Chen, H.-L. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.015 · Cited by 267
Self-citationYan, H., Peng, B., Liu, Y., Xu, G., He, W., Ren, B., Jing, Z., Sui, J., & Li, W. (2014) · Journal of Virology · doi:10.1128/jvi.03478-13 · Cited by 263
Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B
Chen, D.-S. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.002 · Cited by 261
Self-citationChen, H., Lin, L., Hu, F., Lee, J., Lin, W., Yang, Y., Huang, F., Wu, S., Chen, S. C., Wen, W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.035 · Cited by 255
Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan
Chiang, C.-J., Yang, Y.-W., You, S.-L., Lai, M.-S., & Chen, C.-J. (2013) · JAMA · doi:10.1001/jama.2013.276701 · Cited by 247
Papatheodoridis, G. V., Manesis, E., & Hadziyannis, S. J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00094-5 · Cited by 246
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*
Hatzakis, A., Wait, S., Bruix, J., Buti, M., Carballo, M., Cavaleri, M., Colombo, M., Delarocque‐Astagneau, E., Dusheiko, G., Esmat, G., et al. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01499.x · Cited by 235
Self-citation&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200104000-00030 · Cited by 232
Jeng, W.-J., Sheen, I.-S., Chen, Y.-C., Hsu, C.-W., Chien, R.-N., Chu, C.-M., & Liaw, Y.-F. (2013) · Hepatology · doi:10.1002/hep.26549 · Cited by 225
LUNG CANCER AND SMOKING IN SWITZERLAND
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91333-4 · Cited by 220
Minimization of hepatitis B infection by a 25-year universal vaccination program
Ni, Y.-H., Chang, M.-H., Wu, J.-F., Hsu, H.-Y., Chen, H.-L., & Chen, D.-S. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.021 · Cited by 202
Self-citationMcMahon, B. J., Bulkow, L. R., Singleton, R. J., Williams, J., Snowball, M., Homan, C., & Parkinson, A. J. (2011) · Hepatology · doi:10.1002/hep.24442 · Cited by 201
Natural History of Chronic Hepatitis B
McMahon, B. J. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.05.007 · Cited by 196
Cho, J.-Y., Paik, Y.-H., Sohn, W., Cho, H. C., Gwak, G.-Y., Choi, M. S., Lee, J. H., Koh, K. C., Paik, S. W., & Yoo, B. C. (2014) · Gut · doi:10.1136/gutjnl-2013-306409 · Cited by 171
Greenup, A.-J., Tan, P. K., Nguyen, V., Glass, A., Davison, S., Chatterjee, U., Holdaway, S., Samarasinghe, D., Jackson, K., Locarnini, S. A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.038 · Cited by 167
Self-citationNatural history of chronic hepatitis B in Euro-Mediterranean and African Countries
Hadziyannis, S. J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.030 · Cited by 166
Integration of hepatitis B vaccination into national immunisation programmes
Damme, P. V., Kane, M. A., Meheus, A., & Meheus, A. (1997) · BMJ · doi:10.1136/bmj.314.7086.1033 · Cited by 149
Fung, J., Chan, S., Cheung, C. K. Y., Yuen, M., Chok, K., Sharr, W. W., Chan, A. C. Y., Cheung, T. T., Seto, W., Fan, S.-T., et al. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.111 · Cited by 124
Management of Hepatitis B: Our Practice and How It Relates to the Guidelines
Yapalı, S., Talaat, N., & Lok, A. S.-F. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.036 · Cited by 123
Self-citationPossible origins and evolution of the hepatitis B virus (HBV)
LOCARNINI, S. A., Littlejohn, M., Aziz, M. N., & Yuen, L. K. W. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.006 · Cited by 122
Self-citationNatural history of chronic hepatitis B : what exactly has REVEAL Revealed?
Iloeje, U. H., Yang, H., & Chen, C. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02805.x · Cited by 114
Chen, H., Chang, C., Kong, M., Huang, F., Lee, H., Lin, C., Liu, H., Lee, I.-H., Wu, T., Wu, S., et al. (2004) · Hepatology · doi:10.1002/hep.20006 · Cited by 113
Self-citationMaternal transmission of hepatitis B virus in childhood hepatocellular carcinoma
Chang, M., Chen, D., Hsu, H., Hsu, H., & Lee, C. (1989) · Cancer · Cited by 110
Self-citationKao, J., Hsu, H., Shau, W., Chang, M., & Chen, D. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.116277 · Cited by 103
Self-citationSun, Z., Chen, T., Thorgeirsson, S. S., Zhan, Q., Chen, J., Park, J., Lu, P., Hsia, C. C., Wang, N.-J., Xu, L., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt007 · Cited by 99
Hepatitis B Virus Infection, Its Sequelae, and Prevention in Taiwan
Chen, D. (1987) · Springer eBooks · doi:10.1007/978-4-431-68349-0_6 · Cited by 94
Self-citationHatzakis, A. E., Damme, P. V., Alcorn, K., Gore, C., Benazzouz, M., Berkane, S., Buti, M., Carballo, M., Martins, H. C., Deuffic‐Burban, S., et al. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12120 · Cited by 86
Self-citationRuff, T., Gertig, D. M., Otto, B., Gust, I. D., Sutanto, A., Soewarso, T. I., Kandun, N., Marschner, I. C., & Maynard, J. E. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.2.290 · Cited by 82
Mele, A., Tosti, M. E., Mariano, A., Pizzuti, R., Ferro, A. M., Borrini, B. M., Zotti, C. M., Lopalco, P. L., Curtale, F., Balocchini, E., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/528687 · Cited by 80
Lee, C., Hsieh, K., & Ko, Y. (2003) · PubMed · Cited by 65
Wichajarn, K., Kosalaraksa, P., & Wiangnon, S. (2008) · PubMed · Cited by 65
Fighting against viral hepatitis: Lessons from Taiwan
Chen, D. (2011) · Hepatology · doi:10.1002/hep.24500 · Cited by 62
Self-citationLiao, M.-T., Chang, M., Lin, F., Tsai, I., Chang, Y.-W., & Tsau, Y. (2011) · PEDIATRICS · doi:10.1542/peds.2010-3137 · Cited by 49
Tedder, R. S., Rodger, A., Fries, L., Ijaz, S., Thursz, M. R., Rosenberg, W. M., Naoumov, N. V., Banatvala, J. E., Williams, R. L., Dusheiko, G. M., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis1013 · Cited by 45
Su, W., Liu, C.-C., Liu, D., Chen, S.-F., Huang, J.-J., Chan, T., & Chang, M. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir852 · Cited by 45
Bhimma, R., Coovadia, H. M., Adhikari, M., & Connolly, C. A. (2003) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.157.10.1025 · Cited by 39
Cowie, B. C., Carville, K. S., & MacLachlan, J. H. (2013) · Antiviral Therapy · doi:10.3851/imp2654 · Cited by 39
Tajiri, H., Tanaka, H., Brooks, S., & Takano, T. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9721-4 · Cited by 38
Chen, D., LOCARNINI, S. A., Wait, S., Bae, S., Chen, P., Fung, J., Kim, H. S., Lu, S., Sung, J. J. �., Tanaka, J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.029 · Cited by 32
Self-citationHepatitis B vaccination and liver cancer mortality reduction in Korean children and adolescents.
Gwack, J., Park, S. K., Lee, E. H., Park, B., Choi, Y., & Yoo, K. Y. (2011) · PubMed · Cited by 26
Patient Preferences for Hepatitis B Therapy
Lim, S. G., Aung, M. O., Chung, S. W., Soon, C. S., Mak, B., & Lee, K. H. (2012) · Antiviral Therapy · doi:10.3851/imp2482 · Cited by 26
[Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
Li, R., Yang, J.-Y., Gong, J., Li, Y., Huang, Z.-N., Fang, K.-X., Xu, Z.-Y., Liu, C.-B., Zhao, K., & Zhuang, H. (2004) · PubMed · Cited by 23
Aramă, V., Leblebicioğlu, H., Simon, K. A., et al. (2013) · Antiviral Therapy · doi:10.3851/imp2719 · Cited by 22
Long-Term Protection of Hepatitis B Vaccine: Lessons from Alaskan Experience after 15 Years
Chen, D. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00014 · Cited by 21
Self-citationUniversal Hepatitis B Vaccination: Killing 2 Birds with 1 Stone
Kao, J., & Chen, D. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.002 · Cited by 12
Self-citation
Cited by
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Immunobiology and pathogenesis of hepatitis B virus infection
Iannacone, M., & Guidotti, L. G. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00549-4 · Cited by 520
The role of quantitative hepatitis B surface antigen revisited
Cornberg, M., Wong, V. W.-S., Locarnini, S., Brunetto, M., Janssen, H. L. A., & Chan, H. L.-Y. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.009 · Cited by 372
Self-citationChen, C.-H., Lin, C.-L., & Kao, C.-H. (2015) · Medicine · doi:10.1097/md.0000000000002276 · Cited by 61
“distribution of HBV infection decreased progressively with increasing age based on Table 1.(18,19) In our study, the mean age in the HBV infection cohort was 42.”
Background
Metadata
- Authors
- Locarnini, S., Hatzakis, A., Chen, D.-S., & Lok, A.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 62
- Issue
- 1
- Pages
- S76-S86
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2021264347
- Cited by
- 262
- References
- 73
- FWCI
- 24.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.